Role of ultrasonographic features and quantified BRAFV600E mutation in lymph node metastasis in Chinese patients with papillary thyroid carcinoma
Open Access
- 11 January 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
Abstract
The association between cervical lymph node metastasis (LNM) and ultrasonographic features as well as BRAFV600E mutations in patients with papillary thyroid carcinoma (PTC) remained controversial. This study investigated the association between LNM and ultrasonographic features as well as BRAFV600E mutation in Chinese patients with PTC. A total of 280 patients with PTC in China were included in this study. 108 had cervical lymph node metastasis, while 172 had not. Younger age (Ps < 0.05). The BRAFV600E mutation was detected in 81.0% of patients with PTC (226/280). The status of BRAFV600E mutation was not associated with cervical LNM. However, Ct values by PCR and intensity of reactions by immunohistochemistry (IHC) for BRAFV600E expression had shown significant difference between group with and without LNM. Furthermore, an increased proportion of LNM was also found with the incremental intensity of IHC for BRAFV600E expression from weak to strong reaction after adjusted potential confounders. Further studies are required to verify this association and explore the intrinsic mechanism.Keywords
Funding Information
- National Natural Science Foundation of China (81471682, 81471682, 81471682, 81471682, 81471682, 81471682, 81471682, 81471681)
This publication has 40 references indexed in Scilit:
- Relationship between lymphovascular invasion and clinicopathological features of papillary thyroid carcinomaBosnian Journal of Basic Medical Sciences, 2017
- Significance of Allelic Percentage of BRAF c.1799T > A (V600E) Mutation in Papillary Thyroid CarcinomaAnnals of Surgical Oncology, 2014
- Multifocality, But Not Bilaterality, Is a Predictor of Disease Recurrence/Persistence of Papillary Thyroid CarcinomaWorld Journal of Surgery, 2012
- Is the BRAFV600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer?The American Journal of Surgery, 2012
- Well Differentiated Thyroid Carcinoma: Current TreatmentCurrent Treatment Options in Oncology, 2012
- BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid CancerWorld Journal of Surgery, 2011
- Targeting of the BRAF gene in papillary thyroid carcinoma (Review)Oncology Reports, 2009
- Ultrasonography‐guided fine‐needle aspiration of thyroid incidentaloma: correlation with pathological findingsClinical Endocrinology, 2003
- Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomasAPMIS, 2003
- Mutations of the BRAF gene in human cancerNature, 2002